Reassess patient's therapy plan in case of deterioration of asthma control. Possible development of pneumonia in patients w/ COPD. Possible systemic effects include Cushing's syndrome, Cushingoid features, adrenal suppression, growth retardation in childn & adolescents, decreased bone mineral density, cataract, glaucoma, & central serous chorioretinopathy. Monitor height of childn receiving prolonged treatment. Regularly monitor adrenocortical function in patients transferring from oral steroid therapy. Replacement of systemic w/ inhaled therapy may unmask allergies previously controlled by systemic drug. Do not stop treatment abruptly. Consider very rare reports of increases in blood glucose levels when prescribing to patients w/ history of DM. Active or quiescent pulmonary TB. Avoid concomitant use w/ ritonavir. Immediately discontinue treatment in case of paradoxical bronchospasm. Pregnancy & lactation.
Sign Out
